| scholarly article | Q13442814 |
| P50 | author | Charles J Yeo | Q96191880 |
| Anirban Maitra | Q63019787 | ||
| P2093 | author name string | Jordan M Winter | |
| P2860 | cites work | Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity | Q74428893 |
| A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL) | Q74605831 | ||
| Periampullary adenocarcinoma: analysis of 5-year survivors | Q74689801 | ||
| Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines | Q77458971 | ||
| Molecular pathogenesis of pancreatic cancer | Q79120111 | ||
| Familial pancreatic cancer | Q80060492 | ||
| Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene | Q24311652 | ||
| Intraductal papillary mucinous neoplasms of the pancreas: an updated experience | Q24540094 | ||
| A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34 | Q24613943 | ||
| Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers | Q24671334 | ||
| BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets | Q24685106 | ||
| Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis | Q28145585 | ||
| Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays | Q28185685 | ||
| Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours | Q28206040 | ||
| Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray | Q28218205 | ||
| Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene | Q28273369 | ||
| Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma | Q28300339 | ||
| Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group | Q28307042 | ||
| Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes | Q28307762 | ||
| Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis | Q29614405 | ||
| DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). | Q30781823 | ||
| Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. | Q30991221 | ||
| Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. | Q31034362 | ||
| Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. | Q31037582 | ||
| Discovery of novel tumor markers of pancreatic cancer using global gene expression technology | Q31048088 | ||
| Expression profiling of microdissected pancreatic adenocarcinomas | Q31088417 | ||
| Genetic progression in the pancreatic ducts | Q33943167 | ||
| Regulation of the G2/M transition by p53. | Q33943437 | ||
| Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together | Q33953508 | ||
| Intercellular signals regulating pancreas development and function | Q34131171 | ||
| Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 | ||
| Gene discovery using the serial analysis of gene expression technique: implications for cancer research | Q34270355 | ||
| Developmental aspects of early pancreatic cancer. | Q34372450 | ||
| Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
| Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. | Q34514616 | ||
| Estimating the world cancer burden: Globocan 2000 | Q34518922 | ||
| Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
| The molecular genetics of pancreatic ductal carcinoma | Q34527997 | ||
| LKB1 kinase: master and commander of metabolism and polarity | Q34548473 | ||
| Epidemiologic and etiologic factors of pancreatic cancer | Q34684141 | ||
| Increased risk of cancer in the Peutz-Jeghers syndrome | Q34690977 | ||
| K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. | Q34727489 | ||
| p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions | Q34727942 | ||
| Inherited pancreatic cancer: surveillance and treatment strategies for affected families | Q34743083 | ||
| Lineage commitment and cellular differentiation in exocrine pancreas | Q34743136 | ||
| DNA microarray and cancer | Q35029862 | ||
| A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease | Q35076746 | ||
| Genomic microarrays in human genetic disease and cancer | Q35198389 | ||
| Cancer risk in mismatch repair gene mutation carriers | Q35566043 | ||
| Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas | Q35745306 | ||
| Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion | Q35788695 | ||
| Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity | Q35810149 | ||
| BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications | Q35810230 | ||
| K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization | Q35833155 | ||
| The epigenetics of cancer etiology | Q35920461 | ||
| Familial pancreatic carcinoma in Jews | Q35934053 | ||
| Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting | Q36287900 | ||
| The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel | Q36622684 | ||
| Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent | Q38350940 | ||
| Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation | Q38351218 | ||
| KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas | Q40554859 | ||
| Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss | Q40590830 | ||
| Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. | Q40737371 | ||
| Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas | Q40919523 | ||
| Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas | Q41148624 | ||
| Pathology of Cancer of the Pancreas | Q41690575 | ||
| Population-based molecular detection of hereditary nonpolyposis colorectal cancer | Q43783854 | ||
| Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. | Q44049901 | ||
| Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients | Q44314670 | ||
| Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. | Q44342308 | ||
| Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach | Q44957016 | ||
| Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. | Q45345249 | ||
| Development and cancer: lessons learned in the pancreas. | Q46039536 | ||
| Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas | Q47272497 | ||
| Prevalence of familial pancreatic cancer in Germany | Q49303750 | ||
| Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells | Q50119615 | ||
| Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha | Q52172849 | ||
| Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). | Q53411086 | ||
| The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium | Q53424091 | ||
| Human cytogenetics: 46 chromosomes, 46 years and counting. | Q55036139 | ||
| Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer | Q57274830 | ||
| Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden) | Q57948729 | ||
| Comprehensive Proteomic Analysis of Human Pancreatic Juice | Q57979970 | ||
| Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations | Q64917220 | ||
| p53 and K-RAS alterations in pancreatic epithelial cell lesions | Q70545075 | ||
| Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer | Q71839063 | ||
| Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia | Q72018776 | ||
| Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer | Q72086565 | ||
| Overexpression of p53 protein in adenocarcinoma of the pancreas | Q72533115 | ||
| Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells | Q72655848 | ||
| Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer | Q73056162 | ||
| Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas | Q73165767 | ||
| Fanconi anemia gene mutations in young-onset pancreatic cancer | Q73400804 | ||
| p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma | Q73424501 | ||
| Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas | Q73555144 | ||
| Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis | Q73614651 | ||
| Hypermethylation of multiple genes in pancreatic adenocarcinoma | Q73679019 | ||
| Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression | Q73679075 | ||
| Microarray technology and applications: an all-language literature survey including books and patents | Q74250274 | ||
| P433 | issue | 5 | |
| P921 | main subject | pathology | Q7208 |
| pancreatic cancer | Q212961 | ||
| P304 | page(s) | 324-336 | |
| P577 | publication date | 2006-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Hepato Pancreato Biliary | Q15756742 |
| P1476 | title | Genetics and pathology of pancreatic cancer | |
| P478 | volume | 8 |
| Q90642544 | Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study |
| Q52714924 | Antagonizing CD105 enhances radiation sensitivity in prostate cancer. |
| Q90169589 | Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience |
| Q36344287 | Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells. |
| Q41670877 | EMT and Treatment Resistance in Pancreatic Cancer. |
| Q40661606 | Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression |
| Q39952281 | Imaging in Staging and Management of Pancreatic Ductal Adenocarcinoma |
| Q41228738 | Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells |
| Q60958377 | Metabolic Dependencies in Pancreatic Cancer |
| Q27693345 | Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. |
| Q28476402 | pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs |
Search more.